ReviewCureus2025
Geriatric Assessment Tools in Head and Neck Radiation Oncology: An Unmet Need.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The geriatric population faces unique challenges in cancer treatment due to higher rates of comorbidities, which can complicate the risk-benefit analysis of treatment regimens and overall treatment decisions for both physicians and patients. This is especially true for head and neck cancers (HNC) since these patients experience significant treatment-related morbidity. Currently, there are several geriatric assessment (GA) tools available to predict outcomes in older cancer patients treated with surgery or chemotherapy, but no such tool exists to assess the frailty of geriatric patients undergoing radiation therapy for HNC. In this review, we discuss the available geriatric tools, especially those meant for cancer patients, their limitations in HNC patients, and an additional limitation of predicting radiation (RT) treatment outcomes in this challenging group of patients. We also present preliminary data for a new GA tool for HNC patients that can predict premature termination (PT) of treatment or extended treatment (ET) time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.